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Abstract: Among class B β-lactamases, the subclass B2 CphA enzyme is characterized by a unique specificity 
profile. CphA efficiently hydrolyzes only carbapenems. In this work, we generated site-directed mutants that 
possess a strongly broadened activity spectrum when compared with the WT CphA. Strikingly, the 
N116H/N220G double mutant exhibits a substrate profile close to that observed for the broad spectrum subclass 
B1 enzymes. The double mutant is significantly activated by the binding of a second zinc ion under conditions 
where the WT enzyme is non-competitively inhibited by the same ion. 
Abreviations:  WT, wild type; CD, circular dichroism 
 
In vivo, class B β-lactamases (1) require one or two zinc ions as enzymatic cofactors. By efficiently catalyzing 
the hydrolysis of the β-lactam amide bond, these enzymes play a key role in bacterial resistance to this group of 
antibiotics. The metallo-β-lactamase family has been divided into three different subclasses, B1, B2, and B3, on 
the basis of sequence similarities (2, 3). The CphA metallo-β-lactamase produced by Aeromonas hydrophila 
belongs to subclass B2. It is characterized by a uniquely narrow specificity profile. CphA efficiently hydrolyzes 
only carbapenems and shows very poor activity against penicillins and cephalosporins, a behavior in contrast to 
that of metallo-β-lactamases of subclasses B1and B3, which usually exhibit very broad activity spectra against 
nearly all β-lactam compounds, with the exception of monobactams (4, 5). Moreover, in contrast to the BcII 
(Bacillus cereus) and CcrA (Bacteroides fragilis) enzymes belonging to the B1 subclass, and in general to most 
other metallo-β-lactamases, CphA exhibits a maximum activity as a mono-zinc enzyme. The presence of a Zn2+ 
ion in a second low affinity binding site non-competitively inhibits the enzyme with a Ki value of 46 µM at pH 
6.5 (6). Recently, the structure of the mono-zinc CphA enzyme has been solved by x-ray crystallography (7). 
Similar to the known structures of metallo-β-lactamases of subclasses B1 (BcII (8), CcrA (9), IMP-I (10), BlaB 
(11)) and B3 (L1 (12) and FEZ-1 (13)), the x-ray structure of CphA highlights an αββα sandwich with two 
central β-sheets and α-helices on the external faces. The active site is located at the bottom of the β-sheet core. In 
agreement with previous spectroscopic results (14, 15) and site-directed mutagenesis studies (16), these 
structural data show that the sole Zn
2+






site of the A. hydrophila metallo-β-













 sites (see Fig. 1). The histidine residue in position 116 in most metallo-β-lactamases is 
replaced by an asparagine residue in CphA (2, 17). This Asn-116 residue is not responsible for the narrow 
substrate profile of CphA, because the activity of the N116H mutant (where the three-histidine site found in most 
metallo-β-lactamases is recreated) against nitrocefin, benzyl-penicillin, and cephaloridine, although increased, 
remains rather low (16). Moreover, the KD2 values are similar for the N116S mutant and the wild-type enzyme, 
indicating that Asn
116
 does not participate in the binding of the second metal ion. 
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Among the strictly conserved residues (Table I), Arg
121
 is also present in most subclass B1 enzymes, with the 
exception of CcrA and IMP-1 where the arginine is replaced by a cysteine and a serine, respectively. In subclass 
B3, position 121 is occupied by a histidine residue that becomes a ligand for the second zinc ion (12, 13) (Fig. 
1). 
Cysteine 221 is also present in subclasses B1and B2. For CphA, its presence is essential to the interaction with 
the first zinc ion and for β-lactamase activity (3, 14-16). In subclass B1, substitution of the cysteine side chain 
yields a poorly active mono-zinc enzyme but does yield a di-zinc form nearly as active as the WT β-lactamases 
(18). In subclass B3, cysteine 221 is replaced by a serine, which does not interact directly with the second zinc 
ion but with a water molecule located in the active site and may serve as a proton donor during the catalytic 
process (12, 13). 
The analysis of Fig. 1 and Table I indicated that we could progressively, by site-directed mutagenesis, replace 





































These mutations strikingly broadened the CphA activity spectrum. Some mutants efficiently catalyzed the 
hydrolysis of penicillins and cephalosporins in addition to carbapenems. 
FIG. 1: Representation of the zinc binding sites of sub-class B1 (BCII), B2 (CphA), and B3 (Fez-1) β-lactamases. 
Amino acids that coordinate zinc ions are depicted. 
 
 
TABLE I:  Amino acid residues that are strictly conserved in the known subclass Bl, B2, and B3 zinc β-
lactamases The residues in bold indicate the zinc ligands. The only exception is the 116 position in B3 where a 





56 73 79 84 103 116 117 118 120 121 123 134 142 150ca 183 193 195 196 197 199 203 206 217 219 220 221 232 244 263 
B1    D  H  H D  G  T   G  H  D V P L G G C G W H 
B2 D V G G S N T H D R G A T I G G A H T D V P L G N C G Y H 
B3 G L G  G H/Q A D H   A  D G  G H T       S   H 
a Represents the position 150c in the amino acid sequence consensus of class B β-lactamases. 
MATERIALS AND METHODS 
Site-directed Mutagenesis 
The Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA) was used to introduce all the 
mutations. The primers designed for these experiments are listed in Table II. The N220G mutant was constructed 
using pET9a/CphA WT as template. The double mutant N116H/N220G was constructed using pET9a/CphA 
N220G as template. Triple mutants N116H/R121H/ N220G and N116H/N220G/C221S were constructed from 
the N116H/ N220G mutant. The quadruple mutant N116H/R121H/N220G/C221S was made by adding mutation 
C221S to the N116H/R121H/N220G triple mutant. Finally, the triple mutant N116H/R121H/C221S was 
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obtained from the quadruple mutant by replacing Gly
220
 by the asparagine residue found in the wild-type 
enzyme. 
Protein Expression and Purification 
The genes encoding wild-type CphA and the mutant proteins were cloned into pET9a using the BamHI and Ndel 
restriction sites. The different vectors were then introduced into the Escherichia coli strain BL21(DE3) pLysS 
Star (In-vitrogen). Overexpression and purification of the mutant proteins were performed as described for the 
wild-type protein (6, 19) with the following modifications. Bacteria expressing the wild-type protein were grown 
for 8 h at 37 °C in 2XYT medium (Oxoïd, Backingstoke, UK), whereas those expressing the mutants were 
grown for 30 h at 18 °C in the same medium. The temperature was decreased to 18 °C because all the mutant 
proteins were produced mainly in a non-soluble form when the cultures were grown at 37 °C. The 
N116H/R121H/N220G/C221S mutant could never be produced in a soluble form even at 18 °C. The 
N116H/N220G/C221S and N116H/R121H/C221S mutants turned out to be very unstable and could not be 
purified in sufficient quantities for detailed characterization. 
Determination of Kinetic Parameters 
The hydrolysis of the antibiotics was monitored by following the absorbance variation resulting from the 
opening of the β-lactam ring, using a Uvikon 860 spectrophotometer equipped with thermostatically controlled 
cells and connected to a microcomputer via an RS232C serial interface. The wavelength and absorbance 
variations were those described by Matagne et al. (20, 21). Cells with 0.2- to 1-cm path lengths were used, 
depending on the substrate concentrations. When the Km values of the studied enzymes were sufficiently high, 
the kcat and Km parameters were determined either under initial-rate conditions, using the Hanes linearization of 
the Henri-Michaelis-Menten equation, or by analyzing the complete hydrolysis time courses (22). Low and very 
high Km values were determined as Ki values using imipenem or nitrocefin as reporter substrates. In the cases of 
low Km values, the kcat values were obtained from the initial hydrolysis rates measured at saturating substrate 
concentrations, and in the cases of high Km values, kcat was directly derived from the kcat/Km ratio. 
All experiments were performed at 30 °C in 15 mM sodium cacodylate buffer, pH 6.5. Imipenem was from 
Merck Sharp and Dohme Research Laboratories (Rahway, NJ); benzylpenicillin, oxacillin, cephaloridine, and 
cefotaxime were from Sigma; and nitrocefin was from Unipath Oxoid (Basingstoke, UK). 






N220Gfor 5' -CGAGCAGGTGCTCTATGGCGGCTGCATTCTCAAGGAG-3 ' 





TmC221Sfor 5'-GGTCCTCTATGGCGGCAGCATTCTCAAGGAGAAGC-3 ' 
TmC221Srev 5'-GCTTCTCCTTGAGAATGCTGCCGCCATAGAGGACC-3' 
G220Nfor 5' -CGAGCAGGTGCTCTATGGCAACAGCATTCTCAAGGAG-3 ' 
G220Nrev 5' -CTCCTTGAGAATGCTGTTGCCATAGAGCACCTGCTCG-3 ' 
a
 For, forward primer; Rev: reverse primer. 
Enzymatic Measurement in the Presence of Increasing Concentrations of Zinc and Determination of KD2 
Apparent kcat and Km values were measured in the presence of increasing concentrations of zinc at 30 °C in 15 
mM sodium cacodylate, pH 6.5. When binding of the second zinc ion resulted in a complete loss of activity, the 
data were analyzed Equation 1 (6), 
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where kcat/kcat(0) is the ratio between kcat in the presence of zinc and kcat in the absence of added zinc, and KD2 is 
the dissociation constant for the second zinc ion. When binding of the second zinc ion resulted in an incomplete 
loss of activity or in an increase of activity, Equation 2 was used (16), 
 
where α represents the ratio of kcat at saturating zinc concentration over kcat in the absence of added zinc. 
Experimental data were fitted to Equations 1 or 2 by non-linear regression analysis with the help of Kaleida-
Graph for Windows (KaleidaGraph™, version 3.5, Synergy Software). 
Electron Spray Ionization-Mass Spectrometry and Metal Content Determination 
Samples of wild-type and mutant CphA enzymes were equilibrated in 10 mM ammonium acetate buffer (pH 6.5) 
by centrifugal filtration prior to electron spray ionization-mass spectrometry. For each protein mass spectra were 
obtained under both denaturing and native conditions. Denaturation of the protein was performed by dilution of 
the protein in a 50:50 (v/v) water/acetonitrile mixture containing 0.1% formic acid to final concentrations of 2-5 
pmol/µl. The native protein was diluted to 10-15 pmol/µl in 10 mM ammonium acetate. 
All mass spectra were acquired on a Q-TOF1 mass spectrometer (Micromass, UK) equipped with a nanoelectron 
spray ionization source using gold/lead-coated borosilicate needles purchased from Protana (Odense, Denmark). 
Capillary voltage was set at 1250 V and cone voltage at 40 and 60 V for the denatured protein and native protein, 
respectively. Acquisition time was 3-5 min across an mlz range of 400-3000. The mass spectra were processed 
with MassLynx version 3.1 software of Micromass. The instrument was calibrated using a mixture of myoglobin 
and trypsinogen. The zinc content of each protein was derived from the mass difference between the native and 
denatured protein. 
Determination of the Zinc Content Using ICP/MS 
Proteins samples were dialyzed against 15 mM sodium cacodylate, pH 6.5. Protein concentrations were then 
determined by measuring the absorbance at 280 nm (є280 = 38,000 M-1cm-1). Zinc contents were determined by 
inductively coupled plasma mass spectroscopy as previously described (6,16). 
 
TABLE III: Metal binding for wild-type CphA and mutants 
Protein  Electrospray ionization-mass spectrometry 
Assay conditions Mass of protein  ICP/MS Zn
2+
 
content Calculated Measured No. of Zn
2+
 ions 










































2 (expected: 1.6) 











1.7 (expected: 1.4) 
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TABLE IV: Kinetic parameters of the WT, N116H, N220G, and N116H/N220G CphA enzymes Measurements 
were performed at 30 °C in 15 mM sodium cacodylate, pH 6.5. S.D. values are below 10%. For the double 
mutant, values in parentheses are those observed at saturating zinc concentrations. Values for the WT enzyme 
and N116H are from Vanhove et al. (16). 








WT Imipenem 1200 340 3,500,000 
 Benzylpenicillin 0.03 870
a
 35 
 Oxacillin >l >2,000 500 
 Ampicillin <0.0l 2,500
a
 <4 
 Nitrocefin 0.008 1,300 6 
 Cephaloridine <0.006 6,000
a
 <l 
 Cefotaxime >0.0002 >100 2 
N116H Imipenem 150 1,400 110,000 
 Benzylpenicillin 0.4 910 440 
 Nitrocefin 0.09 33 2,700 
 Cephaloridine 0.24 950 250 
N220G Imipenem 390 50 7,800,000 
 Benzylpenicillin 0.06 530° 120 
 Nitrocefin 0.008 400 20 
 Cephaloridine 0.03 5,500° 5.5 
 Cefotaxime 0.009 1,000° 9 
N116H/N220G Imipenem 16(8) 185 (170) 86,000 (47,000) 
 Benzylpenicillin 3.3 (20) 150° (150) 22,000 (130,000) 
 Oxacillin 10 480 21,000 
 Ampicillin 0.8 800 1,000 
 Nitrocefin 0.7 (2) 4(3.7) 175,000 (540,000) 
 Cephaloridine 0.9 (11) 145(145) 6,200 (75,000) 
 Cefotaxime 0.3 (4) 50 (50) 6,000 (80,000) 
a Measured as Ki values. 
 
TABLE V: Initial rates of hydrolysis for the N116H/N220G and some β-lactam antibiotics. The concentration was 
100 µM for each substrate. υ0 is expressed in micromoles of substrate hydrolyzed per minute and per mg of 

















Stability toward Chaotropic Agents 
The stability of the different proteins was studied by fluorescence. The WT and mutant enzymes (0.05 mg/ml) 
were incubated for 16 h in the presence of increasing urea concentrations (0-8 M) at 4 °C. Fluorescence emission 
spectra of the enzymes were recorded at 20 °C with a PerkinElmer Life Sciences LS50B luminescence 
spectrometer using excitation and emission wavelengths of 280 and 333 nm, respectively. 
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Circular Dichroism 
CD spectra of the different enzymes (0.5 mg/ml) were obtained using a Jasco J-810 spectropolarimeter. The 
spectra were scanned at 20 °C with 1-nm steps from 200 to 250 nm (far UV) and from 250 to 310 nm (near UV). 
FIG. 2: Catalytic properties of the N220G and N116H/N220G mutants. Relative kcat values (kcat/kcat(0)) measured 
in the presence of increasing concentrations of zinc. A, N220G and imipenem; B, N220G and nitrocefin; C, 
N116H/N220G and imipenem; D, N116H/N220G and nitrocefin; E, N116H/N220G and benzylpenicillin; F, 
N116H/N220G and cephaloridine; G, N116H/N220G and cefotaxime. The solid curves are the best fit using 
Equation 1 (A) or Equation 2 (B-G). All experiments were performed at 30 °C in 15 mM sodium cacodylate, pH 
6.5. S.D. values are below 10%. The substrate concentrations were 100 µM with the exception of 
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RESULTS 
From a B2 to a B1 Enzyme 
The N220G and N116H/N220G mutants were expressed in E. coli BL21(DE3) pLysS Star and purified to 
homogeneity. The mass of the different proteins was verified by electrospray mass spectrometry. Within 
experimental errors, the mutants were found to exhibit the expected masses (25132.92 versus 25132 Da for 
N220G and 25154.34 versus 25155 for N116H/N220G, Table III). 
The CD spectra of the mutants in the far UV indicated the same a/β ratio as for the wild-type enzyme. CD 
spectra in near UV and fluorescence emission spectra of the N116H/N220G mutant suggest a small 
conformational change in the protein tertiary structure (not shown). 
The stability of the N220G mutant with urea as denaturat-ing agent is similar to that of the WT enzyme. 
Transitions between native and denaturated states occurred near 3 M urea. The N116H/N220G mutant is a little 
less stable than the WT enzyme and the N220G mutant, because the transition already occurred between 2 and 3 
M urea. The enzymes were stored in 15 mM sodium cacodylate, pH 6.5, and in the presence of a free zinc 
concentration lower than 0.4 µM. Under these conditions, the N220G and N116H/N220G proteins contained one 
zinc ion per molecule as reported for the WT β-lactamase (Table III). At a free zinc concentration of 100 µM, 
inductively coupled plasma mass spectroscopy results show that the WT enzyme and the N116H/N220G double 
mutant bind 2 zinc ions per molecule, whereas the N220G mutant binds 1.7 zinc ions per molecule. The activity 
of the two mutants was measured in the absence of added Zn
2+
 (<0.4 µM) with various substrates representing 
the three major families of β-lactam antibiotics, namely carbapen-ems, penicillins, and cephalosporins (Table 
IV). The N116H substitution (16) modified the activity profile of CphA. The mutant was 20-fold less active 
against imipenem, but the kcat values for benzylpenicillin, cephaloridine, and nitrocefin, although significantly 
increased, remained quite low so that imipenem remained the best substrate by two orders of magnitude or more. 
The behavior of N220G CphA is not very different from that of the wild-type enzyme (Table IV). By contrast, 
the substrate profile of the N116H7N220G mutant is completely different. It no longer behaves as a strict 
carbapenemase. It hydrolyzes benzylpenicillin, oxacillin, ampicillin, nitrocefin, cephaloridine, cefuroxime, and 
cefotaxime, in addition to imipenem. When compared with the WT enzyme, the kcat value of the latter decreased 
by 75-fold, but for all the other substrates, the Km values decreased and the kcat values increased (Table IV). 
Moreover, the N116H/N220G mutant efficiently catalyzes the hydrolysis of meropenem, biapenem, CENTA, 
cephalothin, cefaclor, and ceftriaxone (Table V). 
As mentioned before, the mono-zinc form of the wild-type enzyme (observed in the presence of contaminating 
zinc concentration, i.e. ~0.4 µM) is active, and added zinc behaves as a non-competitive inhibitor resulting in 
negligible activity at high Zn
2+
 concentrations with a Ki (KD2) value of 46 µM (6). With imipenem, the behavior 
of N220G was similar to that of the WT, but the KD2 value increased to 86 ± 6 µM (see Fig. 2B). By contrast, 
and despite a decrease of KD2 to 5 ± 0.9 µM, the double mutant retained 50% of activity at saturating Zn
2+ 
concentrations (Fig. 1C). 
In both cases, the addition of Zn
2+
 did not affect the Km values (Table VI). With the other substrates, and as 
already observed with the N116H mutant, the activity of the N116H7 N220G double mutant increased up to 14-
fold in the presence of added zinc (Fig. 1, D-G). Analysis of the experimental curves using Equation 2 yielded 
values of 3 ± 0.24, 9 ± 1.8, 7 ± 1, and 9 ± 1 µM for the dissociation constant of the second zinc ion with 
nitrocefin, benzylpenicillin, cephaloridine, and cefotaxime as substrates, respectively. 
In these cases too, only kcat was affected, Km being unaffected (Table VII). This behavior was also observed for 
N220G, at least for nitrocefin (the activities of this enzyme against benzylpenicillin, cephaloridine, and 
cefotaxime were too low to allow meaningful measurements), and KD2 obtained from this curve using Equation 
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TABLE VI: Influence of zinc concentrations on kcat and Km values for N116H/N220G and imipenem S.D. values 
are below 10%. 




Imipenem <0.4 16 185 
 1 14.4 190 
 5 12.5 190 
 10 10.4 160 
 20 9 170 
 50 8.7 160 
 100 8.5 160 
 1000 8 170 
 
TABLE VII: Influence of zinc concentrations on kcat and Km values for N116H/N220G and nitrocefin, 
benzylpenicillin, cephaloridine, and cefotaxime. S.D. values are below 10%. 






Nitrocefin <0.4 0.69 4 
 2.5 1.36 3 
 5 1.52 3.5 
 10 1.79 3 
 50 2.00 3.4 
 100 2.06 3.7 
Benzylpenicillin <0.4 3.30 150 
 100 20 150 
Cephaloridine <0.4 0.90 145 
 100 11 145 
Cefotaxime <0.4 0.30 50 
 100 4 50 
 
TABLE VIII: Kinetic parameters of the R121H and N116H/R121H/N220G mutants Values in parentheses are for 
the N116H/N220G enzyme in the absence of added zinc. Measurements were performed at 30 °C in 15 mM 
sodium cacodylate, pH 6.5. S.D. values are below 10%. Note that the kcat values of the triple mutant versus 
imipenem and nitrocefin increase, respectively, 1.9- and 2.5-fold at zinc saturation without significant Km 
modification. 
Enzyme Substrate kcat Km 
µ,M 
kcat/Km 
WT Imipenem 1,200 340 3,500,000 
 Benzylpenicillin 0.03 870
a
 35 
 Nitrocefin 0.008 1300 6 
 Cephaloridine <0.006 6,000
a
 <l 
 Cefotaxime >0.0002 > 100 2 
R121H Imipenem 3.6 380 9,500 
 Benzylpenicillin 0.11 11,000
a
 10 
 Nitrocefin 0.003 10 300 
 Cephaloridine 0.03 1,800° 17 
 Cefotaxime 0.0017 245° 7 
N116H/R121H/N220G Imipenem 1.4(16) 63 (185) 22,000 (86,000) 
 Benzylpenicillin 0.35 (3.3) 1,500° (150) 233 (22,000) 
 Nitrocefin 0.5 (0.7) 85(4) 6,000 (175,000) 
 Cephaloridine 0.2 (0.9) 250° (145) 800 (6,200) 
 Cefotaxime 0.1 (0.3) 120° (50) 833 (6,000) 
a Measured as Ki values. 
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From a B2 to B3 enzyme 
Only the R121H and N116H7 R121H/N220G mutants could be produced in E. coli and purified to homogeneity 
in sufficient quantities. Masses were 25169 Da for R121H and 25136 Da for N116H7R121H7N220G, in 
agreement with the theoretical values (Table III). 
The far-UV CD spectra of the mutants are similar to that of the wild-type. The near-UV CD and fluorescence 
emission spectra of these mutants indicated small conformational modifications in the tertiary structure. The 
stabilities of the mutants in the presence of increasing concentrations of urea were a little lower than that of the 
WT. Transitions between native and denaturated states already occurred between 2 and 3 M. 
 
FIG. 3: Catalytic properties of the R121H and N116H/R121H/N220G mutants. Relatives kcat values (kcat/kcat 0)) 
measured in the presence of increasing concentrations of zinc. A, R121H and imipenem; B, 
N116H/R121H/N220G and imipenem; C, R121H and nitrocefin; D, N116H/ R121H/N220G and nitrocefin. The 
solid curves are the best fit using Equation 1 (A) or Equation 2 (B and D). All experiments were performed at 30 
°C in 15 mM sodium cacodylate, pH 6.5. S.D. values are below 10%. The substrate concentrations were 100 
µM. 
 
TABLE IX: KD2 values for the N220G and N116HIN220G mutants The values are derived from the data shown 
in Fig. 1. 
Mutant Substrate KD2 
 
  µM 
N220G Imipenem 86 ±6 
 Nitrocefin 110 ± 10 
N116H/N220G Imipenem 5 ± 0.9 
 Nitrocefin 3 ± 0.24 
 Benzylpenicillin 9 ± 1.8 
 Cephaloridine 7 ± 1 
 Cefotaxime 9 ± 1 
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The activity of these two mutants was measured with imipenem, benzylpenicillin, nitrocefin, cephaloridine, and 
cefotaxime as substrates in the absence of added zinc, i.e. for a free zinc concentration below 0.4 µM (Table 
VIII). Under these conditions, a significant proportion of a di-zinc form was already present for both mutants, 
respectively, 60% for R121H and 40% for N116H/R121H/N220G, in contrast to the wild-type protein and to the 
N220G and N116H/N220G mutants, which were 100% mono-zinc under the same conditions (Table III). With 
imipenem, the R121H mutant was much less active than the wild-type, a loss of activity due to a 300-fold 
decrease of the kcat value. The Km value of benzylpenicillin significantly increased, whereas those of nitrocefin 
and cephaloridine decreased. The kcat/Km values increased significantly only for nitrocefin and cephaloridine but 
did so for different reasons, namely a decrease of Km for the former and an increase of kcat for the latter. The triple 
mutant exhibited a strong decrease of activity versus imipenem (due to a decrease of kcat) and, as for the 
N116H/N220G mutant, a significant increase versus all other substrates due to increased kcat values and, in the 
cases of nitrocefin and cephaloridine, significantly decreased Km values. However, in all cases, the kcat/Km values 
of the triple mutant remained well below those of N116H/N220G. 
The activity of the R121H mutant against imipenem decreased when the zinc concentration increased (Fig. 3A). 
Considering that in the absence of added zinc ([Zn
2+
] < 0.4 µM), 60% of the R121H enzyme is already in a di-
zinc form, KD2 can be estimated to be below 1.0 µM. The activity of R121H with nitrocefin as substrate is 
independent of the zinc concentration (Fig. 3C). Surprisingly, the activity of the N116H/R121H/ N220G mutant 
with imipenem and nitrocefin as substrates increased (1.9- and 2.5-fold, respectively) in the presence of added 
zinc (Fig. 2, B and D). Considering that, in the absence of added zinc ([Zn
2+
] < 0.4 µM), 40% of the 
N116H/R121H/ N220G enzyme was already in a di-zinc form, KD2 can be estimated to be below 1.0 µM. 
DISCUSSION 
From a B2 to Bl Métallo-β-lactamase 
On the basis of sequence alignments, the B2 characteristic motif of CphA has been modified to mimic that found 
in broad spectrum B1enzymes. The N116H mutant has already been studied by Van-hove et al. (16). Here, 
Asn
220
 was replaced by a glycine residue, and the N116H/N220G double mutant was constructed. 
Although the kcat/Km values of the N220G mutant were somewhat increased with benzylpenicillin, nitrocefin, 
cephaloridine, and cefotaxime when compared with the WT protein, its activity versus imipenem also slightly 
increased. These results indicate that the Asn
220
 side chain does not have a significant role in the catalytic 
process and does not influence the residues involved in this process. The mutation results in a higher KD2 value 
for the binding of the second zinc ion (Table IX). Titration of the apoenzyme
2
 of N220G by Zn
2+
 also indicates 
that binding of the second zinc ion is more difficult than with the WT enzyme. The three-dimensional structure 
of the mono-zinc N220G mutant shows that the increased backbone mobility due to the N220G mutation alters 
the ability of Cys
221
 to coordinate the zinc. As a consequence, the zinc ion occupies two sites, the wild-type site 







fourth ligand being Arg
121
 (7). 
TABLE X: Values of (kcat/Km antibiotic)/ ( kcat/Km imipenem) for the CphA WT, N116/N220G, and 
N116H/R121H/N220G CphA mutants, subclass B1 (BcII, IMP-1, and VIM-2), and subclass B3 (L1 and FEZ-1) 
enzymes 
kcat/Km (antibiotic)/kcat/Km (imipenem) 
 CphA (Subclass B2) Subclass Bl Subclass B3 
 WT N116H/N220G  
[Zn] ≥ 0.4 µM 
N116H/N220G  
[Zn] = 100 µM 
N116H/R121H/N220G BeII IMP-1 VIM-2 L1 FEZ-1 
Benzylpenicillin <0.00l 0.23 2.5 0.01 3.75 0.5 1 0.27 0.55 
Cephaloridin <0.00l 0.07 1.4 0.04 0.16 2 0.7 0.13 0.08 
Cefotaxime <0.00l 0.07 1.5 0.04 6 0.3 1.5 3 12 
 
With imipenem as substrate, the di-zinc form of N220G is completely devoid of activity as observed for the 
wild-type CphA. In contrast, with nitrocefin as substrate, the di-zinc form of N220G is more active than the 
mono-zinc form, whereas there is no influence of added zinc on the activity of the WT enzyme versus nitrocefin. 
                                                          
2 K. De Vriendt, unpublished observation. 
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The N116H/N220G double mutant was not as active as the wild-type enzyme against imipenem, but several 
penicillins and cephalosporins were now found to be significantly hydro-lyzed. Thus, recreating the 
characteristic motif of the B1subclass clearly broadens the substrate profile. For this mutant, the kcat/Km values 
for benzylpenicillin, cephaloridine, and cefotaxime are of the same order as, or are only 1 order of magnitude 
lower than the kcat/Km value for imipenem, compared with 4-6 orders for the WT. The kcat/Km value for nitrocefin 
is even 2-fold higher, and this increases to 11-fold in the presence of added zinc (see below). 
With N116H/N220G and as already observed for N116H (16), the di-zinc form is more active against 
benzylpenicillin, cephaloridine, cefotaxime, and nitrocefin than the mono-zinc form, contrary to what happens 
for imipenem. This suggests that imipenem on the one hand, and these latter compounds on the other, are 
hydrolyzed via slightly different mechanisms. However, the hydrolysis of imipenem by the N116H/N220G 
mutant is not totally inhibited by the binding of the second zinc ion, which underscores a significant residual 
activity of the di-zinc form with this substrate. For the latter, the kcat/Km values for benzylpenicillin, nitrocefin, 
cephaloridine, and cefotaxime are of the same order as, or are 1 order of magnitude higher than the kcat/Km value 
for imipenem (Table IV), and the kcat/Km values for all the tested substrates are of the same order of magnitude 
as, or are only 1 order lower than those determined for the subclass B1 BcII enzyme (5), which is considered to 
exhibit a broad activity spectrum. In the N116H/N220G mutant, the affinity for the second metal ion 
(characterized by KD2) increased by 5- to 10-fold suggesting that the His
116
 side chain can interact with the zinc 
ion. This hypothesis was already proposed for the N116H mutant by Vanhove et al. (16) but must be confirmed 
by NMR and perturbed angular correlation experiments and by resolution of the three-dimensional structure of 
the N116H and N116H/N220G mutants. Unfortunately, no suitable crystals have been obtained yet. 
With both mutants, the zinc concentration did not modify the Km values, but kcat decreased for imipenem or 
increased for the other substrates. Such a "non-competitive" inhibition or activation suggests that the substrate 
does not modify the affinity for the second zinc, and vice versa. Accordingly, the KD2 values measured on the 
basis of the activation or inhibition curves were similar within the limits of experimental errors: 86 and 110 µM 
for N220G, and 3-9 µM for N116H/N220G (Table VIII). 
From a B2 to a B3 Metallo-β-lactamase 
The Arg
121
 residue is conserved in the BcII and CphA enzymes. Dal Peraro et al. (23) have shown by quantum 
chemistry calculations that, in the mono-zinc form of BcII, Arg
121
 anchors the Asp
120
 side chain by forming a 
strong ionic bond, ultimately orienting the Zn(II)-bound hydroxide for nucleophilic attack of the antibiotic β-
lactam ring. Moreover, Rasia et al. (24) have shown that the R121H mutation in BcII leads to poor positioning of 
Asp
120
, and thus the kcat values of this mutant are lower than those of WT BcII. Our kinetic results are consistent 
with a similar role for the Arg
121
 residue in CphA, because the kcat value for imipenem is strongly decreased with 
R121H. 
A similar conclusion can be reached by comparing the kinetic parameters of the triple mutant to those of 
N116H/N220G. The kcat values are decreased as in the R121H mutant of BcII. However, the triple mutant, which 
is much less active than N116H/N220G, conserved a relatively broad substrate spectrum with significant 
hydrolysis rates of benzylpenicillin and cephalosporins. Moreover, it was the only mutant for which the binding 
of the second zinc increased the activity versus imipenem. Unfortunately, it was not possible to construct 
proteins more similar to the B3 enzymes, because the mutants with the additional C221S mutation could not be 
produced or were too unstable to allow detailed studies. 
The mutants exhibit another characteristic of B3 enzymes, namely a strongly increased affinity for the second 
Zn
2+
 ion. Indeed, the KD2 value decreased to below 1 µM. Thus, the replacement of the positive Arg
121
 side chain 
by a neutral one enhances the affinity for Zn
2+
, as was also suggested for BcII (8, 25) and CcrA (9). Rasia and 
Vila (24) have shown that the R121H mutation increases the affinity for the second Zn
2+
 ion in BcII and that the 
H121 side chain replaces His
263





In contrast, the R121C mutation does not increase the affinity for the second Zn
2+
 in BcII (26), and the C121R 
mutant of CcrA was isolated in the di-zinc form, although the removal of the second zinc appeared to be 
facilitated (27). All these data and our results indicate that the replacement of Arg
121
 by a neutral residue in 
CcrA, IMP-1, and the sub-class B3 enzymes increases the affinity for the second zinc. Indeed, no mono-Zn
2+ 
form of sub-class B3 enzymes has ever been obtained. 
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CONCLUSION 
Starting with the narrow spectrum A. hydrophila B2 β-lactamase, we have obtained, after introducing two 
mutations, an enzyme with a much broader activity spectrum. The ratio between the kcat/Km for different 
antibiotics and imipenem calculated for different class B β-lactamases and the CphA mutants underscores the 
complete modification of the CphA activity. As the subclass B1and B3 enzymes, the N116H/N220G mutant is 
able to hydrolyze with a similar efficiency carbapenems, penicillins, and cephalosporins (Table X). 
Moreover, rather than being inhibited by a second zinc, the double mutant is activated to various degrees 
(depending upon the substrate) by the addition of a second zinc with a KD2 of about 5 µM. The only exception is 
imipenem, for which a 50% decrease of activity is observed, but with the same KD2 value. It remains to be 
determined if, in the mononuclear double mutant, the sole Zn
2+
 ion is distributed between the two sites as in BcII 
(28). 
Although obtaining a mutant similar to sub-class B3 enzymes proved more difficult, the mutants containing the 
R121H substitution exhibited an increased affinity for the second zinc (a B3 characteristic), and the triple 
mutant, although less active than the double one, also exhibited a broadened substrate profile. The double mutant 
N116H/N220G represents an ideal starting point to test the ability of the enzyme to adapt to the hydrolysis of 
various substrates or groups of substrates by directed evolution. 
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